NCT04285476Active, not recruiting
Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type
Study of the Predictive Value of a Signature of microRNA in Thyroid Cytologies of Undetermined Type
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
The aim is to validate a signature of microRNA (micro Ribonucleic acid) based in a first exploratory study allowing the stratification of the cytologies of indeterminate type and to study and select others. In a first step, the teams will focus on standardising the pre-analytical stages and defining a threshold of positivity. The results of microRNA signature on a cohort of 70 patients will be compared with the ultrasound and then histological data of the resection specimen.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 71 (actual)
- First submitted
- 24 Feb 2020
- Start date
- 17 Jun 2021
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Diseases
- Thyroid cancer
- NCT number
- NCT04285476
What you commit to
- Study type: Interventional
- Participants enrolled: 71
- From 17 Jun 2021 to the primary completion date, 31 Dec 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient whose medical or psychological conditions do not permit them to complete the study or to sign the consent,
- Patient with metastatic cancer distinct from thyroid cancer
- Patient who has stopped treatment (chemotherapy / immunotherapy) for cancer for less than 6 months.
Other
- Patient under guardianship, curatorship or safeguarding of justice
Who the study is looking for
- Man or woman whose Age is ≥ 18 years
- Patient requiring ultrasound for thyroid nodule scanning with established indication of FNAC
- Patient with Bethesda 3, 4 and 5 thyroid nodule
- Informed patient and signed informed consent received
- Patient affiliated to a French medical coverage system
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Regional Du Cancer de Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
| CHU de Nîmes Coordinator of this site? Confirm its status | Nîmes | France | Unknown status |
| CHU de Toulouse Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.